These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 13879935)
21. Quantitation of pituitary corticotropin reserve in man by use of an adrenocortical 11-beta hydroxylase inhibitor (SU-4885). GOLD EM; DIRAIMONDO VC; FORSHAM PH Metabolism; 1960 Jan; 9():3-20. PubMed ID: 13850548 [No Abstract] [Full Text] [Related]
22. Metabolic studies with a steroid isolated from the urine of patients with "salt-losing" congenital adrenal hyperplasia. COPPAGE WS; LIDDLE GW J Clin Endocrinol Metab; 1960 May; 20():729-34. PubMed ID: 13811860 [No Abstract] [Full Text] [Related]
23. [The (in vitro) inhibitor effect of SU-8000 and SU-10603 on 17 alpha-steroid-hydroxylase (17-alpha-OH-ase) in rat testis]. Valencia-Sánchez A; Domínguez-Vargas O Arch Invest Med (Mex); 1972; 3(2):105-22. PubMed ID: 5076174 [No Abstract] [Full Text] [Related]
24. Production of hypospadias in the rat by selective inhibition of fetal testicular 17 alpha-hydroxylase and C17-20-lyase. Goldman AS Endocrinology; 1971 Feb; 88(2):527-31. PubMed ID: 5540068 [No Abstract] [Full Text] [Related]
25. [ACTION OF METOPIRONE (SU-4885) ON THE PITUITARY-ADRENOCORTICAL AXIS OF CRICETOMYS GAMBIANUS]. QUENUM A C R Seances Soc Biol Fil; 1964; 158():785-7. PubMed ID: 14186948 [No Abstract] [Full Text] [Related]
27. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone. Rigel DF; Fu F; Beil M; Hu CW; Liang G; Jeng AY J Pharmacol Exp Ther; 2010 Jul; 334(1):232-43. PubMed ID: 20354176 [TBL] [Abstract][Full Text] [Related]
28. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women. Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845 [TBL] [Abstract][Full Text] [Related]
29. The treatment of congenital adrenal hyperplasia with a depot preparation of prednisolone. KOMROWER GM; LONGSON D Acta Endocrinol (Copenh); 1961 Jan; 36():157-60. PubMed ID: 13752892 [No Abstract] [Full Text] [Related]
30. [The use of an adrenal 11-beta-hydroxylase inhibitor (Metopirone) in the diagnosis of nanism]. PICENI-SERENI L; DE RITIS L; SERENI F Minerva Pediatr; 1961 Dec; 13():1723-8. PubMed ID: 14486359 [No Abstract] [Full Text] [Related]
31. [Neonatal screening of congenital hyperplasia of the adrenal glands (21-hydroxylase deficiency)]. Farriaux JP; Dhondt JL Rev Med Liege; 1984 May; 39(10):460-3. PubMed ID: 6463470 [No Abstract] [Full Text] [Related]
32. Activities of various steroidogenic enzymes in two forms of experimental adrenal hyperplasia. Goldman AS; Winter JS J Clin Endocrinol Metab; 1967 Dec; 27(12):1717-22. PubMed ID: 4293992 [No Abstract] [Full Text] [Related]
33. Studies of steroid metabolism in a case of the hypertensive form of congenital adrenal hyperplasia. REYNOLDS JW; ULSTROM RA J Pediatr; 1962 Aug; 61():290-1. PubMed ID: 14491718 [No Abstract] [Full Text] [Related]
34. [Diuretic effect of Su-4885, inhibitor of 11-beta-hydroxylation in the adrenal cortex]. LEBACQ E; TIRZMALIS A; GOSSART J; DUEZ P Rev Fr Etud Clin Biol; 1961 Nov; 6():916-7. PubMed ID: 14463259 [No Abstract] [Full Text] [Related]
38. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. New MI; Seaman MP J Clin Endocrinol Metab; 1970 Mar; 30(3):361-71. PubMed ID: 4312795 [No Abstract] [Full Text] [Related]